carmustine has been researched along with Lymphoma, T Cell, Peripheral in 6 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikesch, JH | 1 |
| Kuhlmann, M | 1 |
| Demant, A | 1 |
| Krug, U | 1 |
| Thoennissen, GB | 1 |
| Schmidt, E | 1 |
| Kessler, T | 1 |
| Schliemann, C | 1 |
| Pohlen, M | 1 |
| Mohr, M | 1 |
| Evers, G | 1 |
| Köhler, G | 1 |
| Wessling, J | 1 |
| Mesters, R | 1 |
| Müller-Tidow, C | 1 |
| Berdel, WE | 1 |
| Thoennissen, NH | 1 |
| Nademanee, A | 1 |
| Palmer, JM | 1 |
| Popplewell, L | 1 |
| Tsai, NC | 1 |
| Delioukina, M | 1 |
| Gaal, K | 1 |
| Cai, JL | 1 |
| Kogut, N | 1 |
| Forman, SJ | 1 |
| Rodríguez, J | 1 |
| Caballero, MD | 1 |
| Gutiérrez, A | 1 |
| Marín, J | 1 |
| Lahuerta, JJ | 1 |
| Sureda, A | 1 |
| Carreras, E | 1 |
| León, A | 1 |
| Arranz, R | 1 |
| Fernández de Sevilla, A | 1 |
| Zuazu, J | 1 |
| García-Laraña, J | 1 |
| Rifon, J | 1 |
| Varela, R | 1 |
| Gandarillas, M | 1 |
| SanMiguel, J | 1 |
| Conde, E | 1 |
| Bishton, MJ | 1 |
| Haynes, AP | 1 |
| Williams, KM | 1 |
| Higman, MA | 1 |
| Chen, AR | 1 |
| Schwartz, CL | 1 |
| Wharam, M | 1 |
| Colombani, P | 1 |
| Arceci, RJ | 1 |
| Mercadal, S | 1 |
| Briones, J | 1 |
| Xicoy, B | 1 |
| Pedro, C | 1 |
| Escoda, L | 1 |
| Estany, C | 1 |
| Camós, M | 1 |
| Colomo, L | 1 |
| Espinosa, I | 1 |
| Martínez, S | 1 |
| Ribera, JM | 1 |
| Martino, R | 1 |
| Gutiérrez-García, G | 1 |
| Montserrat, E | 1 |
| López-Guillermo, A | 1 |
4 trials available for carmustine and Lymphoma, T Cell, Peripheral
| Article | Year |
|---|---|
High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Child, Preschool; Cy | 2011 |
High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-F | 2003 |
Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Celiac Disease; Combined Modality | 2007 |
Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modalit | 2008 |
2 other studies available for carmustine and Lymphoma, T Cell, Peripheral
| Article | Year |
|---|---|
DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Co | 2013 |
Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antine | 2008 |